Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 6
1989 1
1990 2
1991 5
1992 4
1993 3
1994 1
1995 2
1996 5
1997 5
1998 4
1999 5
2000 5
2001 9
2002 3
2003 8
2004 5
2005 6
2006 5
2007 11
2008 7
2009 13
2010 11
2011 16
2012 11
2013 8
2014 10
2015 14
2016 17
2017 13
2018 10
2019 14
2020 9
2021 17
2022 14
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

266 results

Results by year

Filters applied: . Clear all
Page 1
Challenges in ageing persons with haemophilia.
Makris M, Lassila R, Kennedy M. Makris M, et al. Among authors: lassila r. Haemophilia. 2024 Apr;30 Suppl 3:5-11. doi: 10.1111/hae.14994. Epub 2024 Mar 27. Haemophilia. 2024. PMID: 38539058
Pretreatment with a dual antiplatelet and anticoagulant (APAC) reduces ischemia-reperfusion injury in a mouse model of temporary middle cerebral artery occlusion-implications for neurovascular procedures.
Denorme F, Frösen J, Jouppila A, Lindgren A, Resendiz-Nieves JC, Manninen H, De Meyer SF, Lassila R. Denorme F, et al. Among authors: lassila r. Acta Neurochir (Wien). 2024 Mar 15;166(1):137. doi: 10.1007/s00701-024-06017-x. Acta Neurochir (Wien). 2024. PMID: 38485848 Free PMC article.
Development of a Coagulation Disorders Unit.
Szanto T, Helin T, Joutsi-Korhonen L, Lehtinen AE, El Beayni N, Lepäntalo A, Lassila R. Szanto T, et al. Among authors: lassila r. Semin Thromb Hemost. 2024 Feb 19. doi: 10.1055/s-0044-1779633. Online ahead of print. Semin Thromb Hemost. 2024. PMID: 38373723
What can historical literature on von Willebrand disease teach us?
Thachil J, Lassila R. Thachil J, et al. Among authors: lassila r. Res Pract Thromb Haemost. 2023 Oct 30;7(8):102244. doi: 10.1016/j.rpth.2023.102244. eCollection 2023 Nov. Res Pract Thromb Haemost. 2023. PMID: 38193051 Free PMC article.
Inhibitor development according to concentrate in severe hemophilia: reporting on 1392 Previously Untreated Patients from Europe and Canada.
Fischer K, Lassila R, Peyvandi F, Gatt A, Hollingsworth R, Lambert T, Kaczmarek R, Bettle A, Samji N, Rivard GÉ, Carcao M, Iorio A, Makris M; EUHASS and CHESS participants. Fischer K, et al. Among authors: lassila r. Res Pract Thromb Haemost. 2023 Nov 20;7(8):102265. doi: 10.1016/j.rpth.2023.102265. eCollection 2023 Nov. Res Pract Thromb Haemost. 2023. PMID: 38193044 Free PMC article.
Intravenously administered APAC, a dual AntiPlatelet AntiCoagulant, targets arterial injury site to inhibit platelet thrombus formation and tissue factor activity in mice.
Bonetti NR, Jouppila AS, Saeedi Saravi SS, Cooley BC, Pasterk L, Liberale LL, Gobbato S, Lüscher TF, Camici GG, Lassila RP, Beer JH. Bonetti NR, et al. Among authors: lassila rp. Thromb Res. 2023 Aug;228:163-171. doi: 10.1016/j.thromres.2023.04.010. Epub 2023 Apr 25. Thromb Res. 2023. PMID: 37331119 Free article.
Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance.
Schutgens REG, Jimenez-Yuste V, Escobar M, Falanga A, Gigante B, Klamroth R, Lassila R, Leebeek FWG, Makris M, Owaidah T, Sholzberg M, Tiede A, Werring DJ, van der Worp HB, Windyga J, Castaman G. Schutgens REG, et al. Among authors: lassila r. Hemasphere. 2023 Jun 5;7(6):e900. doi: 10.1097/HS9.0000000000000900. eCollection 2023 Jun. Hemasphere. 2023. PMID: 37304933 Free PMC article.
266 results